← All companies
REGN annual net income
REGENERON PHARMACEUTICALS, INC.
REGN - CIK 0000872589
Market cap$56.80 B
Rank#291
SEC filings985
REGENERON PHARMACEUTICALS, INC. net income by year
REGENERON PHARMACEUTICALS, INC. (REGN) reported net income of $4.50B for fiscal year 2025, as filed in its audited annual report with the SEC.
REGN net income 2011-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $4.50B | +2.1% |
| FY 2024 | $4.41B | +11.6% |
| FY 2023 | $3.95B | -8.9% |
| FY 2022 | $4.34B | -46.3% |
| FY 2021 | $8.08B | +129.9% |
| FY 2020 | $3.51B | +66.0% |
| FY 2019 | $2.12B | -13.4% |
| FY 2018 | $2.44B | +104.0% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does REGENERON PHARMACEUTICALS, INC. make?
REGENERON PHARMACEUTICALS, INC. (REGN) reported net income of $4.50B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has REGENERON PHARMACEUTICALS, INC.'s net income changed over time?
Between fiscal 2011 and fiscal 2025, REGENERON PHARMACEUTICALS, INC.'s net income grew from -$221.76M to $4.50B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.